Physician profile
Robert F Meth
NPI 1053387837
$2,148.41
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $158 · 2021: $444 · 2022: $428 · 2023: $414 · 2024: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $427.76 | 2021-2024 | Hizentra |
| Novartis Pharmaceuticals Corporation | $342.84 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $311.15 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $242.87 | 2019-2021 | |
| Glaxosmithkline, LLC. | $92.27 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.77 | 2020-2022 | |
| Genzyme Corporation | $83.30 | 2019-2021 | |
| Abbvie INC. | $81.40 | 2021-2022 | |
| Pfizer INC. | $69.29 | 2019-2021 | |
| Optinose US, INC. | $65.79 | 2019-2021 | |
| Bio Products Laboratory USA, INC. | $62.28 | 2019-2023 | Coagadex, Gammaplex |
| Alk-Abello, INC | $56.89 | 2019-2021 | |
| Grifols USA, LLC | $53.19 | 2019-2020 | |
| Kaleo, INC. | $41.19 | 2020-2022 | |
| Shire North American Group INC | $24.93 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $24.12 | 2019 | |
| Amgen INC. | $22.03 | 2022 | |
| Horizon Therapeutics Plc | $21.03 | 2019 | |
| Electromed, INC. | $19.83 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Meth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.